BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PALB2, ENSG00000083093, 79728
21 results:

  • 1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
    Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
    J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rare germline variants in palb2 and BRCA2 in familial and sporadic chordoma.
    Xia B; Biswas K; Foo TK; Gomes TT; Riedel-Topper M; Southon E; Kang Z; Huo Y; Reid S; Stauffer S; Zhou W; Zhu B; Koka H; Yepes S; Brodie SA; Jones K; Vogt A; Zhu B; Carter B; Freedman ND; Hicks B; Yeager M; Chanock SJ; Couch F; Parry DM; Monteiro AN; Goldstein AM; Carvalho MA; Sharan SK; Yang XR
    Hum Mutat; 2022 Oct; 43(10):1396-1407. PubMed ID: 35762214
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of cancer in heterozygous relatives of patients with Fanconi anemia.
    McReynolds LJ; Giri N; Leathwood L; Risch MO; Carr AG; Alter BP
    Genet Med; 2022 Jan; 24(1):245-250. PubMed ID: 34906449
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (palb2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.
    Manchanda R; Gaba F; Talaulikar V; Pundir J; Gessler S; Davies M; Menon U;
    BJOG; 2022 Jan; 129(1):e16-e34. PubMed ID: 34672090
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A rare palb2 germline variant causing G2/M cell cycle arrest is associated with isolated myelosarcoma in infancy.
    Beer A; Beck R; Schedel A; von Bonin M; Meinel J; Friedrich UA; Menzel M; Suttorp M; Brenner S; Fitze G; Lange B; Knöfler R; Hauer J; Auer F
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1746. PubMed ID: 34382369
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ablation of the Brca1-palb2 Interaction Phenocopies Fanconi Anemia in Mice.
    Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
    Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A genome-wide association study on medulloblastoma.
    Dahlin AM; Wibom C; Andersson U; Bybjerg-Grauholm J; Deltour I; Hougaard DM; Scheurer ME; Lau CC; McKean-Cowdin R; Kennedy RJ; Hung LT; Yee J; Margol AS; Barrington-Trimis J; Gauderman WJ; Feychting M; Schüz J; Röösli M; Kjaerheim K; ; Januszkiewicz-Lewandowska D; Fichna M; Nowak J; Searles Nielsen S; Asgharzadeh S; Mirabello L; Hjalmars U; Melin B
    J Neurooncol; 2020 Apr; 147(2):309-315. PubMed ID: 32056145
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors.
    Hata C; Nakaoka H; Xiang Y; Wang D; Yang A; Liu D; Liu F; Zou Q; Wei L; Zheng K; Inoue I; You H
    J Hum Genet; 2020 Jul; 65(7):577-587. PubMed ID: 32029870
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy of Radium-223 in bone-metastatic Castration-resistant Prostate cancer with and Without Homologous Repair Gene Defects.
    Isaacsson Velho P; Qazi F; Hassan S; Carducci MA; Denmeade SR; Markowski MC; Thorek DL; DeWeese TL; Song DY; Tran PT; Eisenberger MA; Antonarakis ES
    Eur Urol; 2019 Aug; 76(2):170-176. PubMed ID: 30293905
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutational Profile of Metastatic Breast cancers: A Retrospective Analysis.
    Lefebvre C; Bachelot T; Filleron T; Pedrero M; Campone M; Soria JC; Massard C; Lévy C; Arnedos M; Lacroix-Triki M; Garrabey J; Boursin Y; Deloger M; Fu Y; Commo F; Scott V; Lacroix L; Dieci MV; Kamal M; Diéras V; Gonçalves A; Ferrerro JM; Romieu G; Vanlemmens L; Mouret Reynier MA; Théry JC; Le Du F; Guiu S; Dalenc F; Clapisson G; Bonnefoi H; Jimenez M; Le Tourneau C; André F
    PLoS Med; 2016 Dec; 13(12):e1002201. PubMed ID: 28027327
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
    Churpek JE; Marquez R; Neistadt B; Claussen K; Lee MK; Churpek MM; Huo D; Weiner H; Bannerjee M; Godley LA; Le Beau MM; Pritchard CC; Walsh T; King MC; Olopade OI; Larson RA
    Cancer; 2016 Jan; 122(2):304-11. PubMed ID: 26641009
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors.
    Roversi G; Picinelli C; Bestetti I; Crippa M; Perotti D; Ciceri S; Saccheri F; Collini P; Poliani PL; Catania S; Peissel B; Pagni F; Russo S; Peterlongo P; Manoukian S; Finelli P
    Sci Rep; 2015 Oct; 5():15454. PubMed ID: 26482194
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: palb2 mutation predicts exceptional in vivo response to BMN 673.
    Smith MA; Hampton OA; Reynolds CP; Kang MH; Maris JM; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Wu J; Kurmasheva RT; Wheeler DA; Houghton PJ
    Pediatr Blood Cancer; 2015 Jan; 62(1):91-8. PubMed ID: 25263539
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exploring the roles of palb2 at the crossroads of DNA repair and cancer.
    Pauty J; Rodrigue A; Couturier A; Buisson R; Masson JY
    Biochem J; 2014 Jun; 460(3):331-42. PubMed ID: 24870022
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Breast cancer genome-wide association studies: there is strength in numbers.
    Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
    Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Fanconi anemia/BRCA gene network in zebrafish: embryonic expression and comparative genomics.
    Titus TA; Yan YL; Wilson C; Starks AM; Frohnmayer JD; Bremiller RA; Cañestro C; Rodriguez-Mari A; He X; Postlethwait JH
    Mutat Res; 2009 Jul; 668(1-2):117-32. PubMed ID: 19101574
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.